The NHS estate – what are the opportunities for private investors?
New accounting standards that came into force for the NHS last year have made it even more difficult for trusts to pursue much needed...
Buy and Build – the best of both for healthcare growth
Natalie Wade, corporate and health partner at Mills & Reeve, explains why buy and build can present an alternative strategy for healthcare providers looking...
When data becomes the new currency
David Hall, principal associate, and Charlotte Lewis, senior associate, from national law firm Mills & Reeve discuss the value of data in healthcare
Brexit and...
Key UK GDPR considerations for healthcare organisations in 2022
Jagvinder Singh Kang, partner and international & UK head of IT law at Mills & Reeve explains why 2022 could be an opportune time...
The Paterson Inquiry report: realistic pricing and risk
One of the many failings that the Paterson Inquiry has exposed is around the issue of liability in the independent sector. Who pays when...
Teleradiology: Scanning the horizon
Teleradiology is becoming increasingly accepted and adopted across the globe as demand for diagnostics rises. David Gibson, senior associate in the health team at...
The White Paper’s impact on procurement in healthcare
The government’s recent White Paper seeks to ‘bust bureaucracy’ by removing healthcare services from current procurement rules and replacing them with a new provider...
The EU workforce in a post-Brexit UK
Tracy Yates, consultant at national law firm Mills & Reeve, looks at what the future might hold for the UK’s EU workforce
According to a...
NHS Green planning
Jamie Foster, partner, and Gemma Badger, professional support lawyer in the healthcare commercial team at Hill Dickinson LLP look at sustainability and ESG in the public...
The Paterson Inquiry Report: HR processes and patient safety
Jog Hundle and Stuart Craig, partners at national law firm Mills & Reeve, ask whether HR processes enabled Ian Paterson’s unusual surgical character to...